Quantcast

The Comparative Safety of Multiple Alternative Agents in Refractory Chronic Urticaria Patients

Research paper by Sharon Seth, David A. Khan

Indexed on: 14 Oct '16Published on: 13 Oct '16Published in: The Journal of Allergy and Clinical Immunology: In Practice



Abstract

Patients who have failed traditional treatment of chronic urticaria may require trials of alternative medications. Safety profiles, continuous laboratory monitoring, and physician comfort are often barriers to treatment.

Figure 10.1016/j.jaip.2016.08.010.0.jpg